N-methyl-D-aspartate receptor expression in parvalbumin-containing inhibitory neurons in the prefrontal cortex in bipolar disorder

Bipolar Disorders

Volumn 12, Issue 1, 2010, Pages 95-101

  Bitanihirwe, Byron K Y ^a,b   Lim, Maribel P ^c   Woo, Tsung Ung W ^a,c,d  

^a MCLEAN HOSPITAL   (United States)

^b ETH ZURICH   (Switzerland)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

GABA; Gene expression; In situ hybridization; NMDA; NR2A; Postmortem; Schizophrenia

Indexed keywords

AMFEBUTAMONE; BENZATROPINE; CARBAMAZEPINE; CITALOPRAM; CLONAZEPAM; DONEPEZIL; GABAPENTIN; LITHIUM SALT; LORAZEPAM; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; OLANZAPINE; PARVALBUMIN; PERPHENAZINE; RISPERIDONE; SERTRALINE; TOPIRAMATE; TRIFLUOPERAZINE; VALPROATE SEMISODIUM; ZIPRASIDONE;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GABAERGIC SYSTEM; HUMAN; HUMAN TISSUE; MALE; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BIPOLAR DISORDER; CELL COUNT; FEMALE; HUMANS; MALE; MIDDLE AGED; NEURAL INHIBITION; NEURONS; PARVALBUMINS; PREFRONTAL CORTEX; RECEPTORS, N-METHYL-D-ASPARTATE; RNA, MESSENGER;

EID: 75249086447     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2009.00785.x     Document Type: Article

References (38)

1. Woo TUW, Kim AM, Viscidi E. Disease-specific alterations in glutamatergic neurotransmission on inhibitory interneurons in the prefrontal cortex in schizophrenia. Brain Res 2008, 1218:267-277.
2. Guidotti A, Auta J, Davis JM. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch Gen Psychiatry 2000, 57:1061-1069.
3. Veldic M, Guidotti A, Maloku E, Davis JM, Costa E. In psychosis, cortical interneurons overexpress DNA-methyltransferase 1. Proc Natl Acad Sci USA 2005, 102:2152-2157.
4. Woo TUW, Walsh JP, Benes FM. Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder. Arch Gen Psychiatry 2004, 61:649-657.
5. Lewis DA, Hashimoto T, Volk DW. Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci 2005, 6:312-324.
6. Markram H, Toledo-Rodriguez M, Wang Y, Gupta A, Silberberg G, Wu C. Interneurons of the neocortical inhibitory system. Nat Rev Neurosci 2004, 5:793-807.
7. Freund TF, Katona I. Perisomatic inhibition. Neuron 2007, 56:33-42.
8. DeFelipe J, Farinas I. The pyramidal neuron of the cerebral cortex: morphological and chemical characteristics of the synaptic inputs. Prog Neurobiol 1992, 39:563-607.
9. Hashimoto T, Volk DW, Eggan SM. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci 2003, 23:6315-6326.
10. Bitanihirwe B, Lim M, Kim A, Viscidi E, Woo T-UW. Expression of N-methy-D-aspartate receptors in parvalbumin-containing neurons in the prefrontal cortex in schizophrenia. BMC Psychiatry 2009, 9:71.
11. Kinney JW, Davis CN, Tabarean I, Conti B, Bartfai T, Behrens MM. A specific role for NR2A-containing NMDA receptors in the maintenance of parvalbumin and GAD67 immunoreactivity in cultured interneurons. J Neurosci 2006, 26:1604-1615.
12. Behrens MM, Ali SS, Dao DN. Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase. Science 2007, 318:1645-1647.
13. Olney JW, Farber NB. Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 1995, 52:998-1007.
14. Lisman JE, Coyle JT, Green RW. Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci 2008, 31:234-242.
15. Woo TUW, Shrestha K, Amstrong C, Minns MM, Walsh JP, Benes FM. Differential alterations of kainate receptor subunits in inhibitory interneurons in the anterior cingulate cortex in schizophrenia and bipolar disorder. Schizophr Res 2007, 96:46-61.
16. Conde F, Lund JS, Jacobowitz DM, Baimbridge KG, Lewis DA. Local circuit neurons immunoreactive for calretinin, calbindin D-28k or parvalbumin in monkey prefrontal cortex: distribution and morphology. J Comp Neurol 1994, 341:95-116.
17. Rajkowska G, Goldman-Rakic PS. Cytoarchitectonic definition of prefrontal areas in the normal human cortex: I. Remapping of areas 9 and 46 using quantitative criteria. Cereb Cortex 1995, 5:307-322.
18. Heckers S, Stone D, Walsh J, Shick J, Koul P, Benes FM. Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia. Arch Gen Psychiatry 2002, 59:521-529.
19. Woo TUW, Shrestha K, Lamb D, Minns MM, Benes FM. N-methyl-D-aspartate receptor and calbindin-containing neurons in the anterior cingulate cortex in schizophrenia and bipolar disorder. Biol Psychiatry 2008, 64:803-809.
20. Harrison PJ, Heath PR, Eastwood SL, Burnet PW, McDonald B, Pearson RC. The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: Selective mRNA vulnerability and comparison with their encoded proteins. Neurosci Lett 1995, 200:151-154.
21. Kingsbury AE, Foster OJ, Nisbet AP. Tissue pH as an indicator of mRNA preservation in human post-mortem brain. Brain Res Mol Brain Res 1995, 28:311-318.
22. Chevyreva I, Faull RL, Green CR, Nicholson LF. Assessing RNA quality in postmortem human brain tissue. Exp Mol Pathol 2008, 84:71-77.
23. Lipska BK, Deep-Soboslay A, Weickert CS. Critical factors in gene expression in postmortem human brain: focus on studies in schizophrenia. Biol Psychiatry 2006, 60:650-658.
24. Benes FM, Lim B, Matzilevich D, Subburaju S, Walsh JP. Circuitry-based gene expression profiles in GABA cells of the trisynaptic pathway in schizophrenics versus bipolars. Proc Natl Acad Sci USA 2008, 105:20935-20940.
25. Benes FM, Berretta S. GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 2001, 25:1-27.
26. Knable MB, Barci BM, Webster MJ, Meador-Woodruff J, Torrey EF. Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium. Mol Psychiatry 2004, 9:609-620.
27. Dean B. The neurobiology of bipolar disorder: findings using human postmortem central nervous system tissue. Aust N Z J Psychiatry 2004, 38:135-140.
28. Benes FM. Emerging principles of altered neural circuitry in schizophrenia. Brain Res Brain Res Rev 2000, 31:251-269.
29. Howard A, Tamas G, Soltesz I. Lighting the chandelier: new vistas for axo-axonic cells. Trends Neurosci 2005, 28:310-316.
30. Buzsaki G. Rhythms of the Brain 2006, New York, Oxford University Press
31. Soltesz I. Diversity in the Neuronal Machine 2005, New York, Oxford University Press
32. Uhlhaas PJ, Haenschel C, Nikolic D, Singer W. The role of oscillations and synchrony in cortical networks and their putative relevance for the pathophysiology of schizophrenia. Schizophr Bull 2008, 34:927-943.
33. Deep-Soboslay A, Iglesias B, Hyde TM. Evaluation of tissue collection for postmortem studies of bipolar disorder. Bipolar Disord 2008, 10:822-828.
34. Lundorf MD, Buttenschon HN, Foldager L. Mutational screening and association study of glutamate decarboxylase 1 as a candidate susceptibility gene for bipolar affective disorder and schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2005, 135B:94-101.
35. Beneyto M, Kristiansen LV, Oni-Orisan A, McCullumsmith RE, Meador-Woodruff JH. Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders. Neuropsychopharmacology 2007, 32:1888-1902.
36. Beneyto M, Meador-Woodruff JH. Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder. Neuropsychopharmacology 2008, 33:2175-2186.
37. Scarr E, Pavey G, Sundram S, MacKinnon A, Dean B. Decreased hippocampal NMDA, but not kainate or AMPA receptors in bipolar disorder. Bipolar Disord 2003, 5:257-264.
38. McCullumsmith RE, Kristiansen LV, Beneyto M, Scarr E, Dean B, Meador-Woodruff JH. Decreased NR1, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorder. Brain Res 2007, 1127:108-118.